Fresenius Medical Care AG & Co. KGaA operates within the Kidney dialysis centers sector. In addition to historical fundamental analyses, the complete report available to purchase compares Fresenius Medical Care AG & Co. KGaA with three other health care providers in Europe: Orpea SA of France (2016 sales of 2.84 billion Euro [US$3.41 billion] ), Ramsay Generale De Sante SA of France (2.23 billion Euro [US$2.67 billion] of which 82% was Hospitals/Surgery), and Fresenius SE & Co KGaA (29.47 billion Euro [US$35.34 billion] of which 55% was Fresenius Medical Care).

Sales Analysis. During the year ended December of 2016, sales at Fresenius Medical Care AG & Co. KGaA were 16.23 billion Euro (US$19.46 billion). This is an increase of 6.9% versus 2015, when the company's sales were 15.18 billion Euro. This was the fifth consecutive year of sales increases at Fresenius Medical Care AG & Co. KGaA (and since 2011, sales have increased a total of 77%). Sales of North America saw an increase of 9.0% in 2016, from 10.71 billion Euro to 11.67 billion Euro. Not all segments of Fresenius Medical Care AG & Co. KGaA experienced an increase in sales in 2016: sales of Corporate / Eliminations fell 48.0% to 13.04 million Euro. (However, this segment's sales were only a very small portion of the company's overall sales). Fresenius Medical Care AG & Co. KGaA also experienced decreases in sales in Latin America (down 7.1% to 645.22 million Euro) .